Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2012-06-26

FDA Approved: CITALOPRAM — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA approved Torrent Pharmaceuticals Limited's supplemental application for citalopram under an ANDA, confirming approval of a generic citalopram product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Citalopram (Citalopram hydrobromide)

Snippet

SUPPL AP for CITALOPRAM (CITALOPRAM)